Healthcare benefits program Fertifa has agreed to acquire women’s healthtech company Tuune to expand its care offering. Terms of the deal were not disclosed.
Founded by Shardi Nahavandi, Tuune is a clinical decision support platform designed to help clinicians identify treatment options for hormonal conditions. Its proprietary algorithm draws on clinical research and evaluates up to 70 related conditions, providing a holistic approach.
“When we started Tuune, our mission was to help women understand their bodies and hormones and bring that understanding into their care,” said Nahavandi. “I’m proud that Fertifa will take this work forward and help bring it to more people.”
Building out its benefits platform, Fertifa – whose employer client partners include companies like Lululemon and Meta – previously acquired insurance provider Juniper Reproductive Health to strengthen its family-building offering.
With the addition of Tuune, Fertifa enhances its portfolio across cycle health, fertility, and menopause, bringing hormone-related clinical decision support into its benefits platform.
“Finding the right contraception or menopause treatment can involve a lot of trial and error. Tuune was founded on the belief that women’s healthcare should reflect each person’s symptoms, medical history and needs,” Fertifa shared via LinkedIn. “Its technology draws on thousands of scientific publications and assesses more than 70 symptoms to help clinicians identify personalised, evidence-based treatment options.”
